# Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

> **NCT01760993** · PHASE3 · TERMINATED · sponsor: **Shire** · enrollment: 2 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** SPD489

## Key facts

- **NCT ID:** NCT01760993
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-02-01
- **Primary completion:** 2013-04-01
- **Final completion:** 2013-04-01
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Study was discontinued due to non-safety related business prioritization decisions. No subjects were randomized.
- **Last updated:** 2021-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01760993

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01760993, "Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01760993. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*